Literature DB >> 9024563

Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry.

P A Zimmerman1, D M Hercules, E W Naylor.   

Abstract

In this study, time-of-flight secondary ion mass spectrometry was used to distinguish between blood of normal infants and that of individuals with Smith-Lemli-Opitz (SLO) syndrome. SLO syndrome results in an abnormally low concentration of blood cholesterol and an elevated concentration of 7-dehydrocholesterol. Blood was spotted on filter paper and analyzed directly with no extractions or separations. Results showed that using ratios of fragment ions for cholesterol/dehydrocholesterol, patients with SLO and normal individuals could be unambiguously distinguished. Unknown samples from 28 individuals were obtained and identified correctly.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024563     DOI: 10.1002/(sici)1096-8628(19970131)68:3<300::aid-ajmg10>3.0.co;2-x

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens.

Authors:  L Starck; A Lövgren
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

Review 2.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

Review 3.  Smith-Lemli-Opitz syndrome.

Authors:  Andrea E DeBarber; Yasemen Eroglu; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Expert Rev Mol Med       Date:  2011-07-22       Impact factor: 5.600

4.  Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome.

Authors:  William J Griffiths; Yuqin Wang; Kersti Karu; Emmanuel Samuel; Shane McDonnell; Martin Hornshaw; Cedric Shackleton
Journal:  Clin Chem       Date:  2008-06-12       Impact factor: 8.327

5.  Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.

Authors:  A K Ryan; K Bartlett; P Clayton; S Eaton; L Mills; D Donnai; R M Winter; J Burn
Journal:  J Med Genet       Date:  1998-07       Impact factor: 6.318

6.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.